GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression

Nature Cell Biology

Volumn 15, Issue 2, 2013, Pages 201-213

  Chou, Jonathan ^a,b   Lin, Jeffrey H ^a   Brenot, Audrey ^a   Kim, Jung Whan ^a,d   Provot, Sylvain ^a,c   Werb, Zena ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSERM   (France)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 29B; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANGPL4 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BREAST CANCER; CELL DIFFERENTIATION; CELL LOSS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; LOX GENE; LUNG METASTASIS; METASTASIS INHIBITION; MMP2 GENE; MMP9 GENE; NONHUMAN; ONCOGENE; PDGF GENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR MICROENVIRONMENT; VEGF GENE;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOTYPE; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; PHENOTYPE; TRANSFECTION; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 84873364088     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2672     Document Type: Article

References (70)

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
2. Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292 (2011).
3. Hanahan, D. &Coussens, L. M. Accessories to the crime: functions of cells recruited tothetumormicroenvironment. CancerCell21,309-322 (2012).
4. Lu, P., Weaver, V. M. & Werb, Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196, 395-406 (2012).
5. Yang, J. & Weinberg, R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818-829 (2008).
6. Mani, S.A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
7. Chou, J., Provot, S. & Werb, Z. GATA3 in development and cancer differentiation: cells GATA have it! J. Cell Physiol. 222, 42-49 (2010).
8. Asselin-Labat, M. L. et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 9, 201-209 (2007).
9. Kouros-Mehr, H., Slorach, E. M., Sternlicht, M. D. & Werb, Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127, 1041-1055 (2006).
10. Kouros-Mehr, H. et al. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. CancerCell 13, 141-152 (2008).
11. Yoon, N. K.etal. Higher levelsof GATA3 predict bettersurvival inwomenwith breast cancer. Hum. Pathol. 41, 1794-1801 (2010).
12. Mehra, R. et al. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. CancerRes. 65, 11259-11264 (2005).
13. Jacquemier, J. et al. Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer. Breast Cancer Res. 11, R23 (2009).
14. Usary, J. et al. Mutation of GATA3 in human breast tumors. Oncogene 23, 7669-7678 (2004).
15. Network, C. G. A. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
16. Asselin-Labat, M. L. et al. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol. Cell Biol. 31, 4609-4622 (2011).
17. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
18. Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688 (2007).
19. Tavazoie, S. F. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-152 (2008).
20. Valastyan, S. et al. Apleiotropically actingmicroRNA, miR-31, inhibits breastcancer metastasis. Cell 137, 1032-1046 (2009).
21. Dore, L. C. et al. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc. NatlAcad. Sci. USA 105, 3333-3338 (2008).
22. Ibarra, I., Erlich, Y., Muthuswamy, S. K., Sachidanandam, R. & Hannon, G. J. A role for microRNAs in maintenance of mouse mammary epithelial progenitorcells. Genes Dev. 21, 3238-3243 (2007).
23. Yu, F. et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123 (2007).
24. Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869-10874 (2001).
25. Foulkes, W. D., Smith, I. E. & Reis-Filho, J. S. Triple-negative breast cancer. New Engl. J. Med. 363, 1938-1948 (2010).
26. Neve, R. M.etal. Acollection of breast cancer cell linesfor the study of functionally distinct cancer subtypes. Cancer Cell 10, 515-527 (2006).
27. Debnath, J. & Brugge, J. S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev. Cancer 5, 675-688 (2005).
28. Lee, G.Y., Kenny, P. A., Lee, E. H. & Bissell, M. J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 4, 359-365 (2007).
29. Visvader, J. E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 23, 2563-2577 (2009).
30. Mott, J. L. et al. Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-κB. J. CellBiochem. 110, 1155-1164 (2010).
31. Winbanks, C. E. et al. TGF-ß regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J. Biol. Chem. 286, 13805-13814 (2011).
32. Wang, H. et al. NF-κB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. CancerCell 14, 369-381 (2008).
33. Blenkiron, C. et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 8, R214 (2007).
34. Buffa, F. M. et al. microRNA-associated progression pathways and potential therapeutictargets identified by integrated mRNAand microRNAexpression profiling in breastcancer. CancerRes. 71, 5635-5645 (2011).
35. Enerly, E. et al. miRNA-mRNA integrated analysis reveals rolesformiRNAs in primary breast tumors. PLoS One 6, e16915 (2011).
36. Zhu, M. et al. Integrated miRNA and mRNAexpression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage. Genome Biol. 12, R77 (2011).
37. Aslakson, C. J. & Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. CancerRes. 52, 1399-1405 (1992).
38. Dykxhoorn, D. M. et al. miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 4, e7181 (2009).
39. Lin, E. Y. et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163, 2113-2126 (2003).
40. Ewald, A. J., Brenot, A., Duong, M., Chan, B. S. & Werb, Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev. Cell 14, 570-581 (2008).
41. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
42. Betel, D., Wilson, M., Gabow, A., Marks, D. S. & Sander, C. The microRNA.org resource: targets and expression. Nucl. Acids Res. 36, D149-D153 (2008).
43. Krek, A. et al. Combinatorial microRNA target predictions. Nat Genet. 37, 495-500 (2005).
44. Yu, K. R. et al. CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells 30, 876-887 (2012).
45. Padua, D. et al. TGFß primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133, 66-77 (2008).
46. Yan, W., Cao, Q. J., Arenas, R. B., Bentley, B. & Shao, R. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J. Biol. Chem. 285, 14042-14051 (2010).
47. Chu, I. M. et al. GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells. Oncogene 31, 2017-2027 (2012).
48. Levental, K. R. et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906 (2009).
49. Du, R. et al. HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13, 206-220 (2008).
50. van Rooij, E. et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl Acad. Sci. USA 105, 13027-13032 (2008).
51. Roderburg, C. et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liverfibrosis. Hepatology 53, 209-218 (2010).
52. Wang, B. et al. Suppression of microRNA-29 expression by TGF-ß1 promotes collagen expression and renal fibrosis. J. Am. Soc. Nephrol. 2, 252-265 (2011).
53. Fabbri, M. et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. NatlAcad. Sci. USA 104, 15805-15810 (2007).
54. Nguyen, T. et al. Downregulation of microRNA-29c is associated with hyperme-thylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics 6, 388-394 (2010).
55. Xiong, Y. et al. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51, 836-845 (2009).
56. Sethi, A., Mao, W., Wordinger, R. J. & Clark, A. F. Transforming growth factor-ß induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 52, 5240-5250 (2011).
57. Dumont, N. & Arteaga, C. L. Transforming growth factor-ß and breast cancer: tumor promoting effects of transforming growth factor-ß. Breast Cancer Res. 2, 125-132 (2000).
58. Sanchez-Elsner, T. et al. Synergistic cooperation between hypoxia and transforming growth factor-ß pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 276, 38527-38535 (2001).
59. Hurst, D. R., Edmonds, M. D. & Welch, D. R. Metastamir: the field of metastasis-regulatory microRNA is spreading. CancerRes. 69, 7495-7498 (2009).
60. Lujambio, A. & Lowe, S. W. The microcosmos of cancer. Nature 482, 347-355 (2012).
61. Ma, L. et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol. 28, 341-347 (2010).
62. Kota, J. et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017 (2009).
63. Elenbaas, B. et al. Human breastcancercellsgenerated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15, 50-65 (2001).
64. Hwang, H.W., Wentzel, E.A. & Mendell, J.T. A hexanucleotide element directs microRNA nuclear import. Science 315, 97-100 (2007).
65. Tong, Q. et al. Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290, 134-138 (2000).
66. Wrana, J. L. et al. TGF ß signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014 (1992).
67. Zawel, L. et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617 (1998).
68. Watnick, R. S., Cheng, Y. N., Rangarajan, A., Ince, T. A. & Weinberg, R. A. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. CancerCell 3, 219-231 (2003).
69. Gough, P. J., Gomez, I. G., Wille, P. T. & Raines, E. W. Macrophage expression of active MMP-9 inducesacute plaquedisruption in apoE-deficient mice. J. Clin. Invest. 116, 59-69 (2006).
70. Stingl, J. et al. Purification and unique properties of mammary epithelial stem cells. Nature 439, 993-997 (2006).